New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

Press releases published on May 31, 2026

May 31, 2026

MediDepot Expands Mobility Support Solutions for Rehabilitation and Independent Living

Indeterminate EIN Presswire

16 hours ago

BriaCell Therapeutics Announces Pricing of Offering

Indeterminate GlobeNewswire

16 hours ago

Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026

Indeterminate GlobeNewswire

16 hours ago

Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026

Indeterminate GlobeNewswire

16 hours ago

Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026

Indeterminate GlobeNewswire

May 31, 2026

Glyco Harmony Drops [URGENT REPORT 2026] GlycoHarmony Shocking Complete Scientific Breakdown of Benefits Everyone Is Talking

Indeterminate GlobeNewswire

May 31, 2026

SlimTide Capsules [SHOCKING REPORT 2026] Slim Tide Latest Viral Weight-Loss Supplement Craze, Counterfeit Market Explosion, and Consumer Safety Concerns

Indeterminate GlobeNewswire

May 31, 2026

Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC

Indeterminate GlobeNewswire

May 31, 2026

Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer

Indeterminate GlobeNewswire

May 31, 2026

Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire

May 31, 2026

Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma

Indeterminate GlobeNewswire

May 31, 2026

Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Indeterminate GlobeNewswire

May 31, 2026

SlimTide Truth Revealed (2026 Official Website Risk Warning) Avoid Hidden Fees & Fake Complaints

Indeterminate GlobeNewswire

May 31, 2026

NeuExcell Therapeutics Announces Encouraging Data of NXL-004 in Recurrent Malignant Glioma at 2026 ASCO

Indeterminate GlobeNewswire